Driehaus Capital Management LLC Concert Pharmaceuticals, Inc. Transaction History

Driehaus Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$11.25 - $16.17 $495,180 - $711,738	-44,016 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$12.82 - $17.88 $334,794 - $466,936	-26,115 Reduced 37.24%	44,016 $653,000
Q2 2018 Aug 14, 2018	SELL	$16.83 - $21.66 $502,695 - $646,962	-29,869 Reduced 29.87%	70,131 $1.18 Million
Q4 2017 Feb 14, 2018	SELL	$13.96 - $29.05 $2.27 Million - $4.72 Million	-162,569 Reduced 61.91%	100,000 $2.59 Million
Q3 2017 Nov 14, 2017	BUY	$13.91 - $15.31 $3.65 Million - $4.02 Million	262,569	262,569 $3.87 Million

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.